Radiofrequency ablation of neuroendocrine hepatic metastasis

Surg Oncol Clin N Am. 2011 Apr;20(2):273-9, vii-viii. doi: 10.1016/j.soc.2010.11.002. Epub 2010 Dec 13.


Neuroendocrine cancer commonly metastasizes to the liver and often presents as unresectable disease. Liver resection or debulking most of the tumor provides a survival advantage for patients. Whether used alone or in combination with resection, radiofrequency ablation provides a unique tool to destroy metastases to the liver and spare hepatic parenchyma. Although randomized trials are lacking, retrospective series provide promising data to consider radiofrequency ablation in the management of hepatic neuroendocrine metastases.

Publication types

  • Review

MeSH terms

  • Catheter Ablation*
  • Humans
  • Liver Neoplasms / secondary
  • Liver Neoplasms / therapy*
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / therapy*